BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38668050)

  • 1. A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature.
    Péčová M; Benko J; Péč MJ; Jurica J; Horná S; Bolek T; Hurtová T; Sýkora J; Zeleňák K; Samoš M; Sokol J
    Curr Oncol; 2024 Apr; 31(4):1961-1970. PubMed ID: 38668050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.
    Tu J; Jia Z; Ying X; Zhang D; Li S; Tian F; Jiang G
    Medicine (Baltimore); 2016 Dec; 95(49):e5606. PubMed ID: 27930585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma.
    Zhang W; Zhang ZW; Zhang BX; Huang ZY; Zhang WG; Liang HF; Chen XP
    J Gastrointest Surg; 2019 Sep; 23(9):1788-1800. PubMed ID: 30328072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruptured hepatocellular carcinoma following chemoembolization: a western experience.
    Battula N; Srinivasan P; Madanur M; Chava SP; Priest O; Rela M; Heaton N
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):49-51. PubMed ID: 17287166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma].
    Park YH; Kang SH; Kim SU; Kim DY; Park JY; Ahn SH; Han KH; Chon CY
    Korean J Gastroenterol; 2011 Sep; 58(3):149-52. PubMed ID: 21960103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
    Chu HJ; Lee CW; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    PLoS One; 2015; 10(6):e0129367. PubMed ID: 26107693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
    Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization.
    Siramolpiwat S; Punjachaipornpon T; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Tangaroonsanti A; Bhanthumkomol P; Phumyen A; Yasiri A; Kaewmanee M
    Dig Dis Sci; 2019 Nov; 64(11):3337-3345. PubMed ID: 31073737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency embolization in the treatment of ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Sun JH; Wang LG; Bao HW; Lou JL; Cai LX; Wu C; Chen LM; Zheng SS
    Hepatogastroenterology; 2010; 57(99-100):616-9. PubMed ID: 20698237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
    AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
    Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.
    Zhao Y; Cai G; Zhou L; Liu L; Qi X; Bai M; Li Y; Fan D; Han G
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):357-64. PubMed ID: 23714021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization and bland embolization for hepatocellular carcinoma.
    Tsochatzis EA; Fatourou E; O'Beirne J; Meyer T; Burroughs AK
    World J Gastroenterol; 2014 Mar; 20(12):3069-77. PubMed ID: 24695579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.